Autosomal dominant osteogenesis imperfecta (OI) caused by glycine substitutions in type I collagen is a paradigmatic disorder for stem cell therapy. Bone marrow transplantation in OI children has produced a low engraftment rate, but surprisingly encouraging symptomatic improvements. In utero transplantation may hold even more promise. However, systematic studies of both methods have so far been limited to a recessive mouse model. In this study, we evaluated intrauterine transplantation of adult bone marrow into heterozygous BrtlIV mice. Brtl is a knock-in mouse with a classical glycine substitution in type I collagen (α1(I)-Gly349Cys), dominant trait transmission, and a phenotype resembling moderately severe and lethal OI. Adult bone marrow donor cells from eGFP transgenic mice engrafted in haematopoietic and non haematopoietic tissues, differentiated to trabecular and cortical bone cells, and synthesized up to 20% of all type I collagen in the host bone.
Introduction
Osteogenesis imperfecta (OI) has long been considered a paradigmatic disorder for bone marrow or isolated mesenchymal stem cell (MSC) transplantation for skeletal dysplasias 1 . Severe forms of OI are characterized by extreme bone fragility, fractures, skeletal deformities, and short stature; some severe cases are lethal in the perinatal period. The most common molecular defect in OI is a mutation in COL1A1 or COL1A2, encoding the α1(I) and α2(I) chains of type I collagen, respectively 2, 3 . Surgical reconstruction, bisphosphonate administration, and physical therapy are interventions often used to treat patients with OI, but these approaches yield limited functional improvements 4, 5, 6 . Attempts at gene therapy intervention with antisense oligonucleotides, siRNA, ribozymes or homologous recombination are currently limited to in vitro or ex-vivo studies 7, 8 . No cure is available.
Importantly, mosaic carriers of OI mutations experience mild to no clinical symptoms, suggesting that even a minor fraction of normal osteoprogenitor cells may have significant clinical benefits 9 . In clinical trials of bone marrow transplantation (BMT) with 10,11 or without 12 isolation of MSCs, Horwitz et al. reported just 1-2% engraftment in children with OI, but an increase in bone mineral content by DEXA. Subsequently, Le Blanc et al. achieved 7% engraftment after in utero transplantation of fetal liver donor cells, but any potential phenotypic effects in the patient were masked by bisphosphonate administration 13 . While promising, the results of these human trials are difficult to interpret because of inherent limitations, such as a lack of matched controls and unfeasibility of evaluating engraftment beyond a single biopsy site.
Murine models bypass these limitations, providing not only statistical evaluations of the treatment efficacy, but also better understanding of the engraftment distribution, of the functional status of engrafted cells, and potential side effects. The first bone marrow transplantation for murine OI was performed on a transgenic mouse with a human COL1A1 minigene and resulted in increased collagen and mineral content in bone. 14 
Nyibizi et al. reported 0.3-28% engraftment in
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From bone after transplantation of newborn oim mice with single cells derived from bone marrow osteoprogenitors transduced with a GFP expressing retrovirus and expanded in culture 15 . Recently, Guillot et al. reported ~5% engraftment and skeletal improvements after in utero transplantation of oim mice with fetal MSCs derived from human first trimester blood and transfected with a lentiviral vector expressing eGFP 16 . Unfortunately, most animal studies were limited to the treatment of oim mice with virally transduced cells [15] [16] [17] . Viral transduction may alter the differentiation, proliferation, and function of transplanted cells in vivo 18 . In addition the oim mouse itself is a model of a rare, recessive form of OI with only one known patient 19 . The results obtained in these studies are difficult to extrapolate and implement into a practical treatment of more common OI forms with dominant transmission.
To develop a more clinically relevant and straightforward model, we performed in utero transplantation of heterozygous BrtlIV mice with bone marrow from transgenic mice expressing eGFP. The BrtlIV mouse was developed earlier by a knock-in G1546>T transversion in one col1a1
allele, resulting in a Gly349Cys substitution in the α1(I) chain 20 . Substitution of an obligate glycine, found in every third residue of the helical regions of both type I collagen chains, is by far the most common cause of dominant OI 2, 21 . The BrtlIV mouse has the typical molecular defect, autosomal dominant transmission, and outcomes resembling human patients 20 .
In utero transplantation (IUT) of adult bone marrow or bone marrow-derived MSCs may be advantageous compared to other stem cell treatments. Fetal stem cells may be tumorigenic [22] [23] [24] and their use may be limited by ethical concerns 25 . Adult bone marrow contains progenitor cells for haematopoietic and mesenchymal lineages 1, 26, 27 ; transplantation of these cells may be particularly beneficial in disorders such as OI, in which only limited lineages need to be replaced or restored 28 .
IUT is considered more risky than postnatal BMT, but it may be the only option for preventing early organ failure or fetal mortality and it may have other advantages 29 . In the present study, we measured the cell engraftment in various tissues, and the mineral content, geometry and mechanical properties of bones. However, these well-established parameters may not reveal whether the observed effects are actually caused by the engrafted cells rather than the transplantation process itself 18 . To address this question, we went beyond previous approaches and analyzed the proportions of bone matrix synthesized by the host and engrafted cells, as well as the matrix properties near cells of each origin. This study revealed surprising evidence of higher matrix synthesis activity by donor cells, suggesting that even a relatively low engraftment may offer significant therapeutic benefits for OI and potentially for other bone disorders.
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Materials and Methods

Animals
The mouse model for osteogenesis imperfecta, BrtlIV (129SvJ,C57BL/6, CD1) used for this study was described previously 20 . CMV/eGFP CD-1 transgenic mice, in which the GFP gene is controlled by the CMV promoter/enhancer, were used to obtain donor cells; these mice were a kind gift from 
Intrauterine transplantation
Fresh bone marrow was obtained from hind limbs of 6 to 8 week-old CMV/eGFP CD-1 transgenic mice as described by Dobson et al. 33 . Briefly, femora and tibiae were dissected, cleaned of connective tissue and placed on ice in phosphate-buffered saline solution (PBS 1X, Sigma)
supplemented with 2% fetal bovine serum (FBS, Euroclone). After clipping off the epiphysis, the bones were centrifuged in specialized tubes for 1 minute at 400 g to collect the marrow 34 . Each pellet was resuspended in 0.4 mL of PBS with 2% FBS using a 23-gauge syringe. The marrow obtained from each animal was pooled in one 15 mL tube and centrifuged at 450 g. The pellet was resuspended in 1 mL of ACK lysing buffer (Sigma) for 5 minutes at room temperature. After additional pelleting, the cells were resuspended in PBS, 2% FBS, passed through a 40 µm nylon mesh filter (Millipore) and counted.
Pregnant WT females crossed with BrtlIV heterozygous males underwent allogenic intrauterine transplantation (IUT) at embryonic day (E) 13.5-14.5. A midline laparotomy was performed on anesthetized females and the uterine horns were exteriorized. Each fetus was injected intrahepatically with 6 μL suspension containing 5×10 6 cells through a glass capillary 35 . Uterine horns were replaced, and the wound was closed with absorbable synthetic sutures and staples. The animals were genotyped by PCR using gDNA from tail biopsies 36 .
Tissue examination by fluorescence and confocal microscopy
Spleen, thymus, liver, lung, brain, pancreas, kidney, fat, testis and calvarial bone from sacrificed mice were examined by DMIL-Leica fluorescence microscope. Mice containing eGFP+ cells were used for subsequent studies.
For confocal imaging, long bones from 11 WT and 9 Brtl mice were dissected, cleaned of connective tissues, and fixed in 4% paraformaldehyde (PFA, Sigma) in PBS for 24 h. The bones were then decalcified in 14% EDTA/PBS, pH7.1 for 4 days 37 and incubated in 30% sucrose/PBS for 24 h. All procedures were performed at 4°C in the dark. Bone samples were embedded in optimal cutting temperature compound (O.C.T., Tissue-Tek) and 10 μm cryosections were cut onto superfrost Plus Gold Slides (Thermo Scientific). The nuclei were counterstained by DAPI (0.5 μg/ml). The sections were examined by TCS SP2-Leica confocal microscope.
Fluorescence-activated cell sorting
Suspensions of cells isolated from bone marrow, spleen and peripheral blood were analyzed by a 
Real time PCR
Total DNA was extracted from fat, spleen, liver, bone marrow, thymus, skin, lung, muscle, and brain tissue samples, as well as from entire long bones and calvariae, by cellular lysis and isopropanol precipitation 39 . Real time PCR assays for mouse albumin and eGFP were performed For personal use only. on November 12, 2017. by guest www.bloodjournal.org From orient the long axes of the bones parallel to the image planes, the excised bone specimens were fixed with manufacturer-made plastic holders. The correct longitudinal positioning was determined from an initial "scout scan". The scans were performed at the distal metaphysis of tibiae, proximal metaphysis of femora and diaphysis of both bones. The scans were analysed with pQCT software 6.00B using contour mode 2 and peel mode 2 with a threshold of 350 mg/cm³ for trabecular and total bone and with a threshold of 600 mg/cm 3 for cortical bone.
MicroCT
Left femora from male BrtlIV mice and their WT littermates, with or without IUT, were scanned on a cone beam micro computed tomography system (eXplore Locus SP; GE Healthcare BioSciences, London, Ontario, Canada). The images were calibrated and reconstructed at 10 μm voxel size.
Standardized femoral mid-diaphyseal cortical regions of interest were isolated, thresholded and assessed structurally and densitometrically (Microview ABA; GE Healthcare BioSciences, London, Ontario, Canada). Trabecular compartments within the distal metaphysis of the femur were also isolated, thresholded and evaluated for morphologic and densitometric measures (Microview ABA; GE Healthcare BioSciences, London, Ontario, Canada).
Mechanical testing
Whole-bone mechanical properties were determined by loading the left femora to failure in fourpoint bending using a servohydraulic testing machine (858 Mini Bionix II; MTS Systems, Eden Prairie, MN) at a constant displacement rate of 0.5 mm/s. Femora were loaded in the anteriorposterior direction with the posterior side in tension and the anterior side in compression. Loaddisplacement curves were analyzed with MATLAB 7.1 software (The Mathworks Inc., Natick, MA).
Bone tissue material properties were predicted using standard mechanics of material equations, assuming a bending mode of failure. Data for each μCT outcome measure were assessed with independent sample t-test using SSPS version 16.1. Separate models were used for different genotypes.
CFU-F
Bone marrow cells were isolated from hind limbs of transplanted 2 month old mice as described above and 1×10 7 cells were plated in a 6-well plate (Costar) in Mesencult medium with Supplement (Biocompare). The medium was replaced after 24h. Plastic adherent stromal cells from Brtl and WT treated mice were grown for 1 week, changing the medium twice. CFU-F colonies were stained by Giemsa (Sigma) and analyzed with fluorescence and light microscopy. Only colonies containing >50 cells (all GFP+) were considered positive.
Osteoblast primary cultures
Femora of transplanted mice were cleaned of soft tissue, the metaphyses were removed and the marrow flushed out with cold PBS. Osteoblasts were established according to the Robey and Termine method 40 . Briefly, osteoblasts were released by digesting bone chips for 2h at 37°C with 0.3 units/ml collagenase P in serum-free medium, then grown in α-MEM containing 25 μg/ml ascorbate, 2 mM glutamine and 10% FBS in presence of 5% CO 2 . Osteoblast cultures were analyzed by fluorescence and light microscopy.
Collagen analysis
Trabecular and cortical bone from the interface between the diaphysis and metaphysis were dissected from the distal end of the femur. The residual soft tissue was removed after loosening by partial digestion with 1 mg/ml trypsin (Sigma) in DPBS with calcium and magnesium at and 10-15 cm -1 resolution Raman spectra were recorded in a Senterra confocal Raman microscope (Bruker Optics Inc., Billerica, MA) using a 40X/0.95 objective and 50 μm pinhole. Spectral peaks were analyzed after subtracting straight baselines from solution-corrected spectra.
Results
In Utero transplantation of total bone marrow cells into Brtl and WT embryos
Whole bone marrow cells from long bones of adult CMV/eGFP CD-1 transgenic mice, depleted of red blood cells, were transplanted into livers of E13.5-14.5 embryos from WT females crossed with Brtl males. Although no difference in litter size or in the ability of females to successfully raise pups has been reported for BrtlIV mice, WT dams were chosen to avoid potential delays in recovery from surgery and delivery. The ability of the harvested bone marrow cells to differentiate into osteoblasts and adipocytes was confirmed in vitro by Von Kossa and Oil Red O staining, respectively ( Supplementary Fig.1 ).
A total of 464 fetuses in 56 WT females were transplanted, 36.4% of which (n=169) reached the weaning age (3 weeks). Among the latter 51.4% (n=87) were WT and 48.5% (n=82) were heterozygous BrtlIV, suggesting nearly equal survival of WT and mutant animals (1:1). In untreated animals from our colony, BrtlIV pups had a survival rate two times lower compared to WT and, at the same age of 2 mo, 65.5% were WT and 34.5% were heterozygous BrtlIV , consistent with previous reports 20, 41 . The significantly higher (p=0.04) proportion of surviving BrtlIV animals in transplanted mice indicated that the treatment rescued the genotype-related lethality in our murine model.
The genotype-independent lethality of transplanted mice could be caused by accidental tissue damage during the transplantation (due to the small animal size) or inadequate fostering of the litters which had been neglected by the mothers.
Donor cell engraftment in haematopoietic and non haematopoietic tissues
The transplanted mice were sacrificed at age 2 months, the age at which the Brtl phenotype is most severe compared to WT littermates 42 . Of 135 mice examined, 87 (64.4%) had detectable donor green cells in spleen, thymus, calvarial bone, fat, liver, lung, pancreas and testis ( Figure 1 ). The (Table 1 , Supplementary Fig. 3 ). Haematopoietic chimerism was detected in blood, spleen and bone marrow as well (Table 2 , Supplementary Fig. 4 ).
Further FACS analysis on single cell suspensions ( Figure 2A ) revealed eGFP+ cell engraftment from 0.14 to 6.93% (1.52±1.42, n=41) in spleen and from 0.21 to 11.56% (1.31±2.29, n=30) in bone marrow (Table 3) Table 1) . Thus, the selection of the transplanted mice for further analysis was based on bone marrow FACS measurements. and Brtl (8.51±4.61, n=9) animals (p>0.05). Note, however, that this fraction was considerably higher than the overall donor cell engraftment in cortical bone, since many bone sections did not contain eGFP+ cell patches.
Engraftment in cortical and trabecular bone
Collagen composition in treated and untreated bones from BrtlIV animals
Gel electrophoresis of collagen extracted from trabecular and cortical bones revealed α1(I)-S-S-α1(I) dimers, in addition to α1(I) and α2(I) monomers ( Figure 4A ). These dimers are formed with over 95% efficiency in molecules containing two mutant α1(I) Gly349Cys chains 45, 46 . From the intensities of the α1(I)-S-S-α1(I) and α1(I) bands, we estimated the fraction of collagen molecules with two mutant chains as 26.7±4.3% in trabecular and 25.7±2.5% in cortical bone from untreated animals, consistent with previous reports 41, 46 . In treated animals, this fraction decreased with increasing bone marrow engraftment of donor cells ( Figure 4B ). In animals with the highest engraftment (1.9±0.1%) this fraction was 20.4±2.9% in trabecular and 20.9±2.6% in cortical bone , p<0.01; Figure 5 and Table 4 ). No statistically significant differences were found in other tested parameters (not shown).
MicroCT No difference in the bone mechanics was noted between the treated and untreated WT groups ( Figure 6B ). Interestingly, the predicted strength (109.69±23.97 MPa vs 78.58±18.26, p<0.05) was higher in the treated Brtl than in treated or untreated WT mice ( Figure 6C ).
Microspectroscopic Raman analysis of extracellular matrix mineralization
Samples with eGFP+ osteocytes were selected from ~200 longitudinal, radial femur diaphyseal sections from animals with high bone marrow engraftment. Raman spectra were collected from ~2
μm spots selected at least 3 μm away from osteocyte lacunae in primary lamellar and primary "fine vibrations as independent measures of organic material in the extracellular matrix. The difference in the mineral/matrix ratio near 30 eGFP+ and 66 eGFP-osteocytes was statistically insignificant (p=0.2) both within the lamellar and fine-fibered bone, indicating similar average matrix mineralization near host and transplanted cells ( Figure 7A ). However, the mineral density was significantly less heterogeneous around eGFP+ osteocytes (5.9±1.8% in lamellar and 5.2±0.7% in fine-fibered bone) than around eGFP-osteocytes (10.0±0.8% and 11.9±1.4%, p=0.016 and p=0.006 respectively), as illustrated in Figure 7B .
Discussion
The BrtlIV model of classical, dominant negative OI offers significant advantages for investigating stem cell transplantation compared to the transgenic and recessive oim mice previously utilized [14] [15] [16] [17] .
The primary goal of this work was to define the approach, develop the means, and set the stage for future studies of different treatment aspects. Our observations of (a) a major fraction of bone matrix synthesized by a minor fraction of engrafted osteoblasts, (b) recovery of bone quality in treated mice and (c) rescue of the lethal phenotype, address some existing puzzles and offer insights for future studies. (Table 2 ). Among 0.17±0.08% progenitors (Lin-Sca+CD117-) in the recipient bone marrow, we detected up to 10.4% eGFP+ cells (Table 1) . Thus, the transplanted cells maintained their progenitor potential at least through the prepubertal development of host animals, which is the crucial timeframe for attainment of peak bone mass. Furthermore, some of these transplanted cells differentiated into mature osteoblasts, which synthesized bone matrix with much higher efficiency than endogenous BrtlIV osteoblasts. Biochemical analysis of femur matrix revealed that 1.9±0.1% of donor osteoblasts produced 21±6% of all bone collagen (Figure 4 and Supplementary Table 2 ). Our interpretation is that donor osteoblasts have normal rather than elevated matrix synthesis efficiency, while the cells of the BrtlIV host have strongly reduced efficiency because of ER stress. Our previous studies of BrtlIV animals have suggested that ER stress and cellular malfunction, associated with accumulation and intracellular degradation of mutant collagen molecules, may be a major factor contributing to the animal phenotype 48, 41 .
Low bone engraftment despite noticeable phenotype improvement was observed previously after in utero transplantation of human fetal blood MSCs to oim mice 16 , after allogenic bone [10] [11] [12] , and after in utero transplantation on a 32 week human fetus 13 . The dramatically higher matrix synthesis efficiency by engrafted normal cells offers a clue for the understanding these otherwise puzzling observations.
IUT improves bone geometry and mechanical properties. The high matrix synthesis efficiency may explain how 1-2% engraftment of donor cells can restore the mechanical properties of bone in BrtlIV animals to nearly normal ( Figure 6 ). We evaluated the changes in bone geometry and mechanics in 2 month old mice, the age at which the skeletal phenotype of BrtlIV mice is most severe 42 . Similar increases in cortical thickness and area in IUT treated BrtlIV and WT animals suggested that bone geometry was affected by donor humoral factors or transplantation per se as previously speculated by others 49 .
At the same time, the stiffness, ultimate load, and yield load improved significantly only in Table 2 . FACS analysis of peripheral blood, spleen and bone marrow cells from 2 month old recipient mice (IUT, n=9) and untreated animals (NO IUT, n=4). The antigens used to identified the lineages were: CD45 for haematopoietic cells, CD3 for T lymphocytes, B220 for B lymphocytes, CD11b for myeloid cells, Ly-G6 (Gr-1) for granulocytes and Ter119 for erythroid cells. For each lineage marker, the first line shows the mean fraction of positive cells (%) ± SD. The second line shows the engraftment of eGFP+ cells within the lineage. Table 3 . FACS analysis of overall eGFP+ cell engraftment in spleen and bone marrow from 2 month old BrtlIV and WT recipient mice. 
